These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38423229)

  • 21. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes.
    Bérard A; Zhao JP; Shui I; Colilla S
    Ann Rheum Dis; 2018 Apr; 77(4):500-509. PubMed ID: 29222350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes.
    Zhou Y; Tao J; Wang K; Deng K; Wang Y; Zhao J; Chen C; Wu T; Zhou J; Zhu J; Li X
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):593. PubMed ID: 34470618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of Pregnancies for Women Undergoing Endoscopy While They Were Pregnant: A Nationwide Cohort Study.
    Ludvigsson JF; Lebwohl B; Ekbom A; Kiran RP; Green PH; Höijer J; Stephansson O
    Gastroenterology; 2017 Feb; 152(3):554-563.e9. PubMed ID: 27773807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate.
    Kaplan S; Dragut CF; Ghimpeteanu A
    Curr Med Res Opin; 2024 May; 40(5):821-825. PubMed ID: 38577712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
    Huybrechts KF; Bateman BT; Pawar A; Bessette LG; Mogun H; Levin R; Li H; Motsko S; Scantamburlo Fernandes MF; Upadhyaya HP; Hernandez-Diaz S
    BMJ; 2020 Feb; 368():m237. PubMed ID: 32075794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study.
    Ofori B; Oraichi D; Blais L; Rey E; Bérard A
    Birth Defects Res B Dev Reprod Toxicol; 2006 Aug; 77(4):268-79. PubMed ID: 16929547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors of adverse birth outcomes among a cohort of pregnant women in Coastal Kenya, 2017-2019.
    Mirieri H; Nduati R; Dawa J; Okutoyi L; Osoro E; Mugo C; Wamalwa D; Jin H; Mwaengo D; Otieno N; Marwanga D; Shabibi M; Munyua P; Kinuthia J; Clancey E; Widdowson MA; Njenga MK; Verani JR; Inwani I
    BMC Pregnancy Childbirth; 2024 Feb; 24(1):127. PubMed ID: 38347445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal non-steroidal anti-inflammatory drug exposure during pregnancy and risk of miscarriage: a systematic review and meta-analysis.
    Ying XH; Bao DN; Jiang HY; Shi YD
    Eur J Clin Pharmacol; 2022 Feb; 78(2):171-180. PubMed ID: 34635936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes.
    Phijffer EW; de Bruin O; Ahmadizar F; Bont LJ; Van der Maas NA; Sturkenboom MC; Wildenbeest JG; Bloemenkamp KW
    Cochrane Database Syst Rev; 2024 May; 5(5):CD015134. PubMed ID: 38695784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taking NSAIDs during pregnancy. Is it safe?
    Jackson-Northey K; Evans MF
    Can Fam Physician; 2002 Mar; 48():483-5. PubMed ID: 11935712
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety of topical corticosteroids in pregnancy.
    Chi CC; Wang SH; Wojnarowska F; Kirtschig G; Davies E; Bennett C
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007346. PubMed ID: 26497573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions.
    Daniel S; Koren G; Lunenfeld E; Bilenko N; Ratzon R; Levy A
    CMAJ; 2014 Mar; 186(5):E177-82. PubMed ID: 24491470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal exposure to airborne polychlorinated biphenyls (PCBs) and risk of adverse birth outcomes.
    Kofoed AB; Deen L; Hougaard KS; Petersen KU; Meyer HW; Pedersen EB; Ebbehøj NE; Heitmann BL; Bonde JP; Tøttenborg SS
    Eur J Epidemiol; 2021 Aug; 36(8):861-872. PubMed ID: 34420151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.
    Weber-Schoendorfer C; Oppermann M; Wacker E; Bernard N; ; Beghin D; Cuppers-Maarschalkerweerd B; Richardson JL; Rothuizen LE; Pistelli A; Malm H; Eleftheriou G; Kennedy D; Kadioglu Duman M; Meister R; Schaefer C
    Br J Clin Pharmacol; 2015 Oct; 80(4):727-39. PubMed ID: 25808588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome.
    Wacker E; Navarro A; Meister R; Padberg S; Weber-Schoendorfer C; Schaefer C
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):353-60. PubMed ID: 25644395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
    Sujan AC; Rickert ME; Öberg AS; Quinn PD; Hernández-Díaz S; Almqvist C; Lichtenstein P; Larsson H; D'Onofrio BM
    JAMA; 2017 Apr; 317(15):1553-1562. PubMed ID: 28418479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of diclofenac use during early pregnancy: A prospective observational cohort study.
    Padberg S; Tissen-Diabaté T; Dathe K; Hultzsch S; Meixner K; Linsenmeier V; Meister R; Schaefer C
    Reprod Toxicol; 2018 Apr; 77():122-129. PubMed ID: 29477808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.
    Thiel S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
    Mult Scler; 2016 May; 22(6):801-9. PubMed ID: 26920382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy outcomes following maternal exposure to statins: A systematic review and meta-analysis.
    Karadas B; Uysal N; Erol H; Acar S; Koc M; Kaya-Temiz T; Koren G; Kaplan YC
    Br J Clin Pharmacol; 2022 Sep; 88(9):3962-3976. PubMed ID: 35639354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.